bobbybobby
MercadosAccionesÚnete

D-Wave Quantum Soars on $100M CHIPS Act Grant

Sep 8, 2026
Equipo Quant de Bobby

💡 Puntos Clave

D-Wave's $100 million government grant is a positive catalyst, but equal awards to rivals and a larger one to GlobalFoundries mean it's not a unique advantage.

What Happened: D-Wave Lands $100M Government Deal

D-Wave Quantum (QBTS) announced a definitive agreement with the U.S. Department of Commerce to receive up to $100 million in funding under the CHIPS and Science Act. The news sent D-Wave stock up nearly 11% in morning trading.

The funding is earmarked to help D-Wave scale, commercialize, and manufacture its domestic quantum capabilities, including strengthening the supply chain for building quantum computers. In exchange, the government will receive a minority, non-controlling equity stake in the company, though the exact percentage hasn't been disclosed.

Given D-Wave's market cap of $6.7 billion, a $100 million investment could translate to roughly a 1.5% stake. This is a significant vote of confidence from the U.S. government in D-Wave's technology and its role in national security and economic competitiveness.

However, D-Wave isn't the only quantum company getting a boost. Rivals Quantinuum (QNT) and Rigetti Computing (RGTI) also received similar $100 million awards under the CHIPS Act, and their stocks rose 7-8% on the news.

Even more notable, GlobalFoundries (GFS), a larger semiconductor company, received a $375 million award—more than the three pure-play quantum companies combined. This suggests the government is spreading its bets across the quantum and semiconductor landscape.

Why It Matters: Government Backing Validates Quantum Sector

This news is a major validation for the quantum computing industry, signaling that the U.S. government sees quantum as a strategic priority. For D-Wave, the funding provides capital to accelerate its roadmap and expand manufacturing, which could shorten the path to profitability.

The equity stake means the government has skin in the game, aligning its interests with D-Wave's success. This could also open doors to future government contracts, as D-Wave becomes a preferred partner in federal quantum initiatives.

However, the fact that competitors received identical awards tempers the competitive advantage. D-Wave is not being singled out as the national champion; instead, the government is supporting multiple players to ensure a robust domestic quantum ecosystem.

For investors, this means the sector as a whole gets a boost, but individual stock performance will depend on execution and commercial traction. D-Wave's focus on annealing quantum computers differentiates it from gate-based rivals like IBM and Google, but it still faces technical and market challenges.

The larger award to GlobalFoundries highlights that the government is also investing in the broader semiconductor supply chain, which could benefit companies that support quantum hardware manufacturing.

Fuente: The Motley Fool
Análisis generado por el modelo cuantitativo de Bobby AI, revisado y editado por nuestro equipo de investigación. Esto no constituye asesoramiento financiero. Investigue por su cuenta antes de tomar decisiones de inversión.

icon

Bobby Insight

bobby-insight

D-Wave's grant is a positive but not game-changing catalyst; hold for long-term quantum potential but don't chase the pop.

The $100 million is meaningful but not unique, as rivals got the same. D-Wave's high valuation and dilution risk from the equity stake warrant caution. However, the government backing provides a floor of support and validates the technology.

¿Cómo Me Afecta?

means-for-me
If you hold QBTS, this news is a positive signal but consider taking some profits given the run-up. For investors in QNT or RGTI, the equal funding means your holdings also benefit from sector tailwinds. Those with exposure to GFS might see modest upside from the larger award, but it's likely already priced in. Diversify across quantum and semiconductor names to manage risk.

Más Análisis

Producto

Socios

Mercados

Acciones

© 2026 FLOW AI PTE. LTD. Todos los derechos reservados.

Bobby, the world's first financial AI Agent, is developed by Flow AI, an AI-driven company. Flow AI is dedicated to providing global investors with AI-powered financial services across multiple markets.

Waffo.com Limited (distribuidor autorizado): RM 1903, Piso 19, Lee Garden One, 33 Hysan Avenue, Causeway Bay, Hong Kong.

iconicon

¿Cómo Me Afecta?

If you hold QBTS, this news is a positive signal but consider taking some profits given the run-up. For investors in QNT or RGTI, the equal funding means your holdings also benefit from sector tailwinds. Those with exposure to GFS might see modest upside from the larger award, but it's likely already priced in. Diversify across quantum and semiconductor names to manage risk.
Bobby
cs@bobby.ai
Bobby AI
RockFlow Platform
Acciones
Macroeconomía
Industria
NVDA
AAPL
MSFT
AMZN
GOOG
META
TSLA
Política de Privacidad
Términos de Uso
iconicon

Acciones Relacionadas

AccionesImpactoAnálisis
QBTS
Positivo
D-Wave received $100 million CHIPS Act funding, boosting its ability to scale and commercialize quantum technology, leading to an 11% stock surge.
QNT
Positivo
Quantinuum also received $100 million, validating its quantum computing approach and driving a 7% stock increase.
RGTI
Positivo
Rigetti Computing secured $100 million in funding, supporting its quantum development and lifting its stock 7.4%.
GFS
Neutral
GlobalFoundries received the largest award of $375 million, but its stock only rose 2.86% as the market likely expected such support given its size.

Rigetti Computing Soars on $100M Government Funding

Neutral Rigetti's $100M CHIPS Act award validates quantum computing's strategic importance, but the stock remains highly speculative without meaningful revenue.

RGTIRGTIWQBTSINTC
Sep 8, 2026

Rivian vs Lucid: Executive Exodus Signals Trouble

Alcista Rivian's CFO departure is a smooth evolution, while Lucid's executive exodus signals deeper crisis, making RIVN a stronger long-term EV investment.

RIVNLCIDGEVVWAGY
Sep 9, 2026

CRISPR Therapeutics Stock Jumps 19% on Strong Q2

Alcista CRISPR's Q2 beat and Casgevy momentum signal a turning point, but investors should stay patient for pipeline progress.

CRSPVRTX
Sep 8, 2026